Jnj 10181457 dihydrochloride
CAS: 544707-20-2
Ref. 3D-UWA70720
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Información del producto
JNJ 10181457 is a modulator of the modulation of acetylcholine and noradrenaline. It binds to an antigen in the brain, which is believed to be involved in Alzheimer's disease. JNJ 10181457 has been studied in clinical trials for the treatment of Alzheimer's disease. This drug also has potential for use as an immunotherapy for autoimmune diseases and cancer. JNJ 10181457 is a wake-promoting agent that interacts with dopamine receptors, but it also has antipsychotic effects due to its binding to H1 receptors. JNJ 10181457 also has anti-hyperactivity properties, which are likely related to its interactions with histamine receptors.
Propiedades químicas
Consulta técnica sobre: 3D-UWA70720 Jnj 10181457 dihydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
